• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jacLink to Publisher's site
J Antimicrob Chemother. Nov 2008; 62(5): 929–933.
Published online Aug 27, 2008. doi:  10.1093/jac/dkn334
PMCID: PMC2566517

Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element



Vibrio cholerae O1 from a 2006 outbreak in Accra were commonly resistant to multiple antimicrobials and, in particular, to trimethoprim/sulfamethoxazole, drugs commonly used in the treatment of cholera. We sought to determine the genetic basis for trimethoprim/sulfamethoxazole resistance in outbreak isolates.


Twenty-seven isolates from the outbreak were screened by PCR and sequencing for class 1 and 2 integrons and for the SXT element.


Twenty-one of the 27 isolates examined, all from the Accra metropolitan area, carried both SXT, an integrated chromosomal element, and a class 2 integron bearing dfrA1, sat and aadA1 cassettes. All these isolates had identical random amplification of polymorphic DNA profiles and two of them also carried a class 1 integron.


Most strains characterized carried multiple elements conferring resistance to trimethoprim. This suggests that trimethoprim/sulfamethoxazole should not be used empirically in cholera treatment.

Keywords: trimethoprim resistance, antimicrobial resistance, antibiotic resistance, cholera

Articles from Journal of Antimicrobial Chemotherapy are provided here courtesy of Oxford University Press


Related citations in PubMed

See reviews...See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...